John V. Heymach
0000-0001-9068-8942
Publication & Citation Trends
Publications
0 total
Loss of payload sensitivity and other mechanisms of resistance to T-DXd in HER2-mutant NSCLC: implications for subsequent responsiveness to HER2 TKIs.
Cited by 2
Semantic Scholar
Multi-Site Profiling of Small Cell Lung Cancer and Assessment of Tumor Heterogeneity Through Rapid Research Autopsy
Cited by 0
Semantic Scholar
DNA damage response signatures are associated with frontline chemotherapy response and routes of tumor evolution in extensive stage small cell lung cancer OA
Cited by 6
Semantic Scholar
Combination Surface Targeting Strategies in Relapsed Small Cell Lung Cancer (SCLC) to Overcome Intratumoral Heterogeneity Associated with Treatment Resistance
Cited by 0
Semantic Scholar
Reconstructing Small Cell Lung Cancer Evolution using Deep Whole Genome Sequencing of Circulating Tumor DNA
Cited by 0
Semantic Scholar
NOTCH1 Acts as a Tumor Suppressor That Induces Early Differentiation in Head and Neck Cancer
Cited by 0
Semantic Scholar
Perioperative Durvalumab for Resectable Non-Small-Cell Lung Cancer. Reply. OA
Cited by 12
Semantic Scholar
Th2 Cells Are Associated with Tumor Recurrence Following Radiation OA
Cited by 2
Semantic Scholar
Research Topics
Lung Cancer Treatments and Mutations
(1030)
Cancer Immunotherapy and Biomarkers
(563)
Lung Cancer Research Studies
(411)
Cancer Genomics and Diagnostics
(333)
RNA modifications and cancer
(283)
Affiliations
AstraZeneca (United Kingdom)
Broad Institute
Dartmouth College
Northwestern University
Hebron University